Cipla’s Proventil Generic Gnaws At US Market

Cipla’s generic of Merck & Co’s Proventil makes significant inroads in the US, with the Indian company confident that it has both a strong cost position and large capacity to take on competition. Pricing in the segment currently remains ‘respectable’.

Cipla's albuterol generic makes inroads in the US • Source: Shutterstock

Cipla Limited’s albuterol generic appears to be off to a promising start in the US chipping away at market share, with the company confident of its cost competitiveness and the scope for interchangeability in the segment.

Cipla had in April received the go-ahead for the first generic of Merck & Co., Inc..’s Proventil HFA (albuterol...